Kowa Co.,Ltd.
Kowa Co.,Ltd. (7807.T) Financial Performance & Income Statement Overview
Explore the financials of Kowa Co.,Ltd. (7807.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Kowa Co.,Ltd. (7807.T) Income Statement & Financial Overview
Explore comprehensive income reports for Kowa Co.,Ltd. 7807.T, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.52B | $1.57B | $1.55B | $1.73B |
Cost of Revenue | $858.90M | $879.00M | $872.54M | $933.11M |
Gross Profit | $664.99M | $691.00M | $676.55M | $791.95M |
Gross Profit Ratio | $0.44 | $0.44 | $0.44 | $0.46 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $543.10M | $514.00M | $0.00 | $470.38M |
Operating Expenses | $543.10M | $513.00M | $477.20M | $493.38M |
Total Costs & Expenses | $1.40B | $1.39B | $1.35B | $1.43B |
Interest Income | $3.22M | $0.00 | $861000.00 | $311000.00 |
Interest Expense | $3.46M | $0.00 | $4.21M | $4.43M |
Depreciation & Amortization | $59.71M | $53.75M | $92.96M | $46.42M |
EBITDA | $248.56M | $230.75M | $292.31M | $340.85M |
EBITDA Ratio | $0.16 | $0.15 | $0.19 | $0.20 |
Operating Income | $121.89M | $178.00M | $199.34M | $298.57M |
Operating Income Ratio | $0.08 | $0.11 | $0.13 | $0.17 |
Other Income/Expenses (Net) | $60.71M | -$9.00M | $88.76M | -$8.57M |
Income Before Tax | $182.60M | $169.00M | $288.10M | $290.00M |
Income Before Tax Ratio | $0.12 | $0.11 | $0.19 | $0.17 |
Income Tax Expense | $65.03M | $80.00M | $92.38M | $59.01M |
Net Income | $115.57M | $84.00M | $190.26M | $225.90M |
Net Income Ratio | $0.08 | $0.05 | $0.12 | $0.13 |
EPS | $27.95 | $19.47 | $43.94 | $52.82 |
Diluted EPS | $27.95 | $19.51 | $44.11 | $52.12 |
Weighted Avg Shares Outstanding | $4.14M | $4.31M | $4.35M | $4.28M |
Weighted Avg Shares Outstanding (Diluted) | $4.14M | $4.31M | $4.33M | $4.33M |
Over the past four quarters, Kowa Co.,Ltd. demonstrated steady revenue growth, increasing from $1.73B in Q1 2024 to $1.52B in Q4 2024. Operating income reached $121.89M in Q4 2024, maintaining a consistent 8% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $248.56M, reflecting operational efficiency. Net income rose to $115.57M, with EPS at $27.95. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan